357 related articles for article (PubMed ID: 11127576)
1. Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing.
Mansfield SG; Kole J; Puttaraju M; Yang CC; Garcia-Blanco MA; Cohn JA; Mitchell LG
Gene Ther; 2000 Nov; 7(22):1885-95. PubMed ID: 11127576
[TBL] [Abstract][Full Text] [Related]
2. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.
Liu X; Jiang Q; Mansfield SG; Puttaraju M; Zhang Y; Zhou W; Cohn JA; Garcia-Blanco MA; Mitchell LG; Engelhardt JF
Nat Biotechnol; 2002 Jan; 20(1):47-52. PubMed ID: 11753361
[TBL] [Abstract][Full Text] [Related]
3. 5' exon replacement and repair by spliceosome-mediated RNA trans-splicing.
Mansfield SG; Clark RH; Puttaraju M; Kole J; Cohn JA; Mitchell LG; Garcia-Blanco MA
RNA; 2003 Oct; 9(10):1290-7. PubMed ID: 13130143
[TBL] [Abstract][Full Text] [Related]
4. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
Liu X; Luo M; Zhang LN; Yan Z; Zak R; Ding W; Mansfield SG; Mitchell LG; Engelhardt JF
Hum Gene Ther; 2005 Sep; 16(9):1116-23. PubMed ID: 16149910
[TBL] [Abstract][Full Text] [Related]
5. Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting.
Bruscia E; Sangiuolo F; Sinibaldi P; Goncz KK; Novelli G; Gruenert DC
Gene Ther; 2002 Jun; 9(11):683-5. PubMed ID: 12032687
[TBL] [Abstract][Full Text] [Related]
6. A generalizable strategy for imaging pre-mRNA levels in living subjects using spliceosome-mediated RNA trans-splicing.
Walls ZF; Puttaraju M; Temple GF; Gambhir SS
J Nucl Med; 2008 Jul; 49(7):1146-54. PubMed ID: 18552150
[TBL] [Abstract][Full Text] [Related]
7. Spliceosome-mediated RNA trans-splicing as a tool for gene therapy.
Puttaraju M; Jamison SF; Mansfield SG; Garcia-Blanco MA; Mitchell LG
Nat Biotechnol; 1999 Mar; 17(3):246-52. PubMed ID: 10096291
[TBL] [Abstract][Full Text] [Related]
8. Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing.
Puttaraju M; DiPasquale J; Baker CC; Mitchell LG; Garcia-Blanco MA
Mol Ther; 2001 Aug; 4(2):105-14. PubMed ID: 11482981
[TBL] [Abstract][Full Text] [Related]
9. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.
Steiner B; Truninger K; Sanz J; Schaller A; Gallati S
Hum Mutat; 2004 Aug; 24(2):120-9. PubMed ID: 15241793
[TBL] [Abstract][Full Text] [Related]
10. Rapid and reliable genotyping of polymorphic loci modifying correct splicing of CFTR pre-mRNA using mass spectrometry.
Schaller A; von Känel T; Gehr B; Sanz J; Gallati S
Eur J Hum Genet; 2007 Jan; 15(1):53-61. PubMed ID: 17024213
[TBL] [Abstract][Full Text] [Related]
11. Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR.
Goncz KK; Colosimo A; Dallapiccola B; Gagné L; Hong K; Novelli G; Papahadjopoulos D; Sawa T; Schreier H; Wiener-Kronish J; Xu Z; Gruenert DC
Gene Ther; 2001 Jun; 8(12):961-5. PubMed ID: 11426337
[TBL] [Abstract][Full Text] [Related]
12. Delay in synthesis of the 3' splice site promotes trans-splicing of the preceding 5' splice site.
Takahara T; Tasic B; Maniatis T; Akanuma H; Yanagisawa S
Mol Cell; 2005 Apr; 18(2):245-51. PubMed ID: 15837427
[TBL] [Abstract][Full Text] [Related]
13. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A-->G, 2751+2T-->A, 296+1G-->C, 1717-9T-->C-D565G) and one nonsense mutation (E822X) in the CFTR gene.
Tzetis M; Efthymiadou A; Doudounakis S; Kanavakis E
Hum Genet; 2001 Dec; 109(6):592-601. PubMed ID: 11810271
[TBL] [Abstract][Full Text] [Related]
14. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice.
Ostrowski LE; Yin W; Diggs PS; Rogers TD; O'Neal WK; Grubb BR
Gene Ther; 2007 Oct; 14(20):1492-501. PubMed ID: 17637798
[TBL] [Abstract][Full Text] [Related]
15. A novel donor splice site characterized by CFTR mRNA analysis induces a new pseudo-exon in CF patients.
Costantino L; Claut L; Paracchini V; Coviello DA; Colombo C; Porcaro L; Capasso P; Zanardelli M; Pizzamiglio G; Degiorgio D; Seia M
J Cyst Fibros; 2010 Dec; 9(6):411-8. PubMed ID: 20875776
[TBL] [Abstract][Full Text] [Related]
16. Insertion of natural intron 6a-6b into a human cDNA-derived gene therapy vector for cystic fibrosis improves plasmid stability and permits facile RNA/DNA discrimination.
Boyd AC; Popp F; Michaelis U; Davidson H; Davidson-Smith H; Doherty A; McLachlan G; Porteous DJ; Seeber S
J Gene Med; 1999; 1(5):312-21. PubMed ID: 10738548
[TBL] [Abstract][Full Text] [Related]
17. Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.
Aznarez I; Chan EM; Zielenski J; Blencowe BJ; Tsui LC
Hum Mol Genet; 2003 Aug; 12(16):2031-40. PubMed ID: 12913074
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation.
Chiba-Falek O; Kerem E; Shoshani T; Aviram M; Augarten A; Bentur L; Tal A; Tullis E; Rahat A; Kerem B
Genomics; 1998 Nov; 53(3):276-83. PubMed ID: 9799593
[TBL] [Abstract][Full Text] [Related]
19. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
20. Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing.
Chao H; Mansfield SG; Bartel RC; Hiriyanna S; Mitchell LG; Garcia-Blanco MA; Walsh CE
Nat Med; 2003 Aug; 9(8):1015-9. PubMed ID: 12847523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]